Last updated on January 2019

Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)


Brief description of study

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD

Detailed Study Description

This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the correction of anemia and maintenance of Hb in subjects with NDD-CKD

Clinical Study Identifier: NCT02648347

Contact Investigators or Research Sites near you

Start Over

Akebia Therapeutics

Research Site
Cooper City, FL United States
  Connect »

Akebia Therapeutics

Research Site
Pembroke Pines, FL United States
3.75miles
  Connect »

Akebia Therapeutics

Research Site
Hollywood, FL United States
8.23miles
  Connect »

Akebia Therapeutics

Research Site
Lauderdale Lakes, FL United States
8.5miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.